Verseon

esign, test, and synthesize never-been-seen molecules atom by atom that may soon become life-changing drugs. We began our mission in 2002 and since have created our proprietary platform based on fundamental scientific advances built in-house. We are currently a clinical-stage company making great strides in cardiovascular disease, diabetic retinopathy, cancer, and liver disease with over a dozen drug candidates in active development. Our mission is to change the standard of care for every disease we address.